Free Delivery for Orders >150k Sh. in Dar. [See>Fees]

Orodar tablets – 3’s

  • Sulfadoxine: 500 mg per tablet
  • Pyrimethamine: 25 mg per tablet
  • Total Therapeutic Dose: 1500mg Sulfadoxine / 75mg Pyrimethamine

Sh 3,000

- +
Add a review
Orodar tablets - 3's Orodar tablets - 3's
Overall rating*
0/5
* Rating is required
Overall, how was your experience with this product?*
0/5
* Rating is required
How easy was it to use the product or service?*
0/5
* Rating is required
Was the product worth the price?
0/5
* Rating is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
0.0
Based on 0 reviews
5 star
0%
4 star
0%
3 star
0%
2 star
0%
1 star
0%
0 of 0 reviews

Sorry, no reviews match your current selections

Share this Product

Orodar is indicated for the following therapeutic and prophylactic applications:

  • Uncomplicated Malaria Treatment: Used to cure acute, uncomplicated cases of P. falciparum malaria in areas where the parasite remains sensitive to Sulfadoxine/Pyrimethamine (SP).
  • Intermittent Preventive Treatment in Pregnancy (IPTp): The definitive public health use. The drug is administered at scheduled antenatal visits under Directly Observed Treatment (DOT) to prevent malaria in the placenta, thereby reducing maternal anemia and infant low birth weight.
STANDARD ADULT DOSAGE: For Orodar (Sulfadoxine/Pyrimethamine), the required single therapeutic dose for both treatment and IPTp is THREE (3) TABLETS taken together.
Dosage and Administration

The entire dose must be taken at once, as a single administration:

  • Standard Adult Dose (IPTp/Treatment): Three (3) tablets are taken simultaneously.
  • Administration: Swallow the tablets whole with food or a glass of milk. Food intake is critical as it significantly improves drug absorption and minimizes gastrointestinal side effects.
  • IPTp Schedule: Doses are typically administered at each scheduled Antenatal Care (ANC) visit, starting in the second trimester, with doses separated by at least one month.
Severe Warnings and Contraindications

Due to the sulfonamide component, Orodar requires careful medical supervision:

IMMEDIATE ATTENTION REQUIRED: If you develop a fever, sore throat, or a widespread, severe skin rash (with or without blisters), stop taking Orodar immediately and seek emergency medical care. These symptoms can signal life-threatening severe skin reactions (e.g., Stevens-Johnson Syndrome).
  • Sulfa Allergy: Contradicted in patients with a history of hypersensitivity to sulfonamides or Pyrimethamine.
  • G6PD Deficiency: Use is cautioned in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, as it can trigger severe hemolytic anemia.
  • Megaloblastic Anemia: Should not be used in patients with pre-existing megaloblastic anemia due to confirmed folate deficiency.
Side Effects and Interactions

Common Side Effects: Nausea, vomiting, headache, and mild skin reactions.

Drug Interactions: Concurrent use with other drugs that inhibit folic acid metabolism, such as Trimethoprim or Methotrexate, is dangerous as it significantly increases the risk of adverse blood disorders.

Orodar Summary Table (3-Tablet Dose)
Detail Information
Active Components Sulfadoxine (500mg) / Pyrimethamine (25mg)
Standard Adult Dose THREE (3) Tablets (Single Dose)
Primary Program Use IPTp (Intermittent Preventive Treatment in Pregnancy) under DOT
Warning Focus Severe Skin Reactions, Sulfa Allergy, G6PD Deficiency
 
  • Pay via Mobile Money, bank, or card.
  • Payments are safe and encrypted.
Delivery Across Tanzania
  • We deliver to all regions.
  • Orders arrive in 2–4 business days.
  • Same-day delivery in Dar es Salaam.
  • Free delivery for orders above TZS 250,000.
 
  • Licensed by the Pharmacy Council of Tanzania.
  • All products are genuine.
  • Registration can be verified online.

Login or Register to instantly unlock special wholesale price discounts for eligible products.

Start Now

Diabetics or
Hypetensive?

Introducing JaliCare
  • Get Monthly medicine delivery.
  • Consumables Discounts.
  • Excepts Health Check-ins.

Reviews

There are no reviews yet

Add a review
Orodar tablets - 3's Orodar tablets - 3's
Overall rating*
0/5
* Rating is required
Overall, how was your experience with this product?*
0/5
* Rating is required
How easy was it to use the product or service?*
0/5
* Rating is required
Was the product worth the price?
0/5
* Rating is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review

Details

Orodar is indicated for the following therapeutic and prophylactic applications:

  • Uncomplicated Malaria Treatment: Used to cure acute, uncomplicated cases of P. falciparum malaria in areas where the parasite remains sensitive to Sulfadoxine/Pyrimethamine (SP).
  • Intermittent Preventive Treatment in Pregnancy (IPTp): The definitive public health use. The drug is administered at scheduled antenatal visits under Directly Observed Treatment (DOT) to prevent malaria in the placenta, thereby reducing maternal anemia and infant low birth weight.
STANDARD ADULT DOSAGE: For Orodar (Sulfadoxine/Pyrimethamine), the required single therapeutic dose for both treatment and IPTp is THREE (3) TABLETS taken together.
Dosage and Administration

The entire dose must be taken at once, as a single administration:

  • Standard Adult Dose (IPTp/Treatment): Three (3) tablets are taken simultaneously.
  • Administration: Swallow the tablets whole with food or a glass of milk. Food intake is critical as it significantly improves drug absorption and minimizes gastrointestinal side effects.
  • IPTp Schedule: Doses are typically administered at each scheduled Antenatal Care (ANC) visit, starting in the second trimester, with doses separated by at least one month.
Severe Warnings and Contraindications

Due to the sulfonamide component, Orodar requires careful medical supervision:

IMMEDIATE ATTENTION REQUIRED: If you develop a fever, sore throat, or a widespread, severe skin rash (with or without blisters), stop taking Orodar immediately and seek emergency medical care. These symptoms can signal life-threatening severe skin reactions (e.g., Stevens-Johnson Syndrome).
  • Sulfa Allergy: Contradicted in patients with a history of hypersensitivity to sulfonamides or Pyrimethamine.
  • G6PD Deficiency: Use is cautioned in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, as it can trigger severe hemolytic anemia.
  • Megaloblastic Anemia: Should not be used in patients with pre-existing megaloblastic anemia due to confirmed folate deficiency.
Side Effects and Interactions

Common Side Effects: Nausea, vomiting, headache, and mild skin reactions.

Drug Interactions: Concurrent use with other drugs that inhibit folic acid metabolism, such as Trimethoprim or Methotrexate, is dangerous as it significantly increases the risk of adverse blood disorders.

Orodar Summary Table (3-Tablet Dose)
Detail Information
Active Components Sulfadoxine (500mg) / Pyrimethamine (25mg)
Standard Adult Dose THREE (3) Tablets (Single Dose)
Primary Program Use IPTp (Intermittent Preventive Treatment in Pregnancy) under DOT
Warning Focus Severe Skin Reactions, Sulfa Allergy, G6PD Deficiency

Q & A

Ask a question
Orodar tablets - 3's Orodar tablets - 3's
Your question
* Question is required
Name
* Name is required
There are no questions yet

Similar related Products

What is a name of your medicine
I dont remember my Medicines
UPLOAD PRESCRIPTION
Maximum file size: 2 GB
When do you want us to deliver?
User Email
User Phone

By clicking 'Submit,' you agree to our AfyaDepo Partner Terms and Conditions.

jQuery(document).on('click', '.prescription-btn', function() { // Get product data from button attributes const productId = jQuery(this).attr('data-product-id'); const productTitle = jQuery(this).attr('data-product-title'); // Set values in the popup form const popup = jQuery('#elementor-popup-modal'); popup.find('input[name="product_id"]').val(productId); popup.find('input[name="product_title"]').val(productTitle); // Debugging (optional) console.log("Product ID:", productId, "Title:", productTitle); });